Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

Literature DB >> 28975564

Comment on: "Targeting the PGD₂/CRTH₂/DP₁ Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

İnsu Yılmaz¹, Murat Türk².

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 28975564 DOI： 10.1007/s40265-017-0821-2

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

Keyword Cloud
References

× No keyword cloud information.

14 in total

1. Aspirin-Exacerbated Respiratory Disease--New Prime Suspects.

Authors: Tanya M Laidlaw; Joshua A Boyce
Journal: N Engl J Med Date: 2016-02-04 Impact factor: 91.245

2. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.

Authors: Grazyna Bochenek; Joanna Kuschill-Dziurda; Krystyna Szafraniec; Hanna Plutecka; Andrzej Szczeklik; Ewa Nizankowska-Mogilnicka
Journal: J Allergy Clin Immunol Date: 2013-08-27 Impact factor: 10.793

3. Association between severity of asthma and degree of chronic rhinosinusitis.

Authors: David C Lin; Rakesh K Chandra; Bruce K Tan; Whitney Zirkle; David B Conley; Leslie C Grammer; Robert C Kern; Robert P Schleimer; Anju T Peters
Journal: Am J Rhinol Allergy Date: 2011 Jul-Aug Impact factor: 2.467

4. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

Authors: R Pettipher; M G Hunter; C M Perkins; L P Collins; T Lewis; M Baillet; J Steiner; J Bell; M A Payton
Journal: Allergy Date: 2014-07-14 Impact factor: 13.146

5. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma.

Authors: Malgorzata Pierzchalska; Zsuzsanna Szabó; Marek Sanak; Jerzy Soja; Andrzej Szczeklik
Journal: J Allergy Clin Immunol Date: 2003-05 Impact factor: 10.793

Review 10. Targeting the PGD₂/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.

Authors: Maciej Kupczyk; Piotr Kuna
Journal: Drugs Date: 2017-08 Impact factor: 9.546

Comment on: "Targeting the PGD₂/CRTH₂/DP₁ Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

1. Aspirin-Exacerbated Respiratory Disease--New Prime Suspects.

2. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.

3. Association between severity of asthma and degree of chronic rhinosinusitis.

4. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

5. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma.

6. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.

7. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.

8. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.

Review 9. Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Review 10. Targeting the PGD₂/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.

Review 9. Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Review 10. Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.

Review 10. Targeting the PGD₂/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.